Immatics NV (FRA:4A3) FFO


FRA:4A3 Immatics NV FRA:4A3
57 GF Score
Price €8.86
GF Value €2.77
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Immatics NV FFO?

FFO (Funds from operations) only applies to REITs.

FRA:4A3
57GF Score
Immatics NV FRA:4A3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Immatics NV (FRA:4A3) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of €8.86 is trading 219.7% above its estimated GF Value™ of €2.77. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for FRA:4A3:

  • FFO:
  • GF Value™: €2.77 vs. price of €8.86 (219.7% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the FRA:4A3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immatics NV Business Description

Other Exchanges IMTX:USA
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
57GF Score

Get the complete analysis for FRA:4A3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.86
Price
€2.77
GF Value